These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. MacLeod A, Daly C, Khan I, Vale L, Campbell M, Wallace S, Cody J, Donaldson C, Grant A. Cochrane Database Syst Rev; 2001 Apr 18; (3):CD003234. PubMed ID: 11687058 [Abstract] [Full Text] [Related]
27. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cody J, Daly C, Campbell M, Donaldson C, Khan I, Vale L, Wallace S, Macleod A. Cochrane Database Syst Rev; 2005 Jul 20; (3):CD003895. PubMed ID: 16034913 [Abstract] [Full Text] [Related]
29. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M, Roberts A, Davies S, Rees A. Drugs; 2004 Jul 20; 64(11):1181-96. PubMed ID: 15161326 [Abstract] [Full Text] [Related]
32. Interventions for non-oliguric hyperkalaemia in preterm neonates. Vemgal P, Ohlsson A. Cochrane Database Syst Rev; 2007 Jan 24; (1):CD005257. PubMed ID: 17253550 [Abstract] [Full Text] [Related]
33. Statins for multiple sclerosis. Wang J, Xiao Y, Luo M, Zhang X, Luo H. Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008386. PubMed ID: 21154395 [Abstract] [Full Text] [Related]
36. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM. Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154 [Abstract] [Full Text] [Related]